Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 8Prostatic Neoplasms 7Leukemia, Myeloid, Acute 6Colorectal Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Congenital Abnormalities 4Pancreatic Neoplasms 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lung Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Venous Thromboembolism 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Neuroblastoma 2Neoplasm Metastasis 2Motor Activity 2Melanoma 2Lymphoma, Follicular 2Lymphoma 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2

Interventions

Oxaliplatin 14Fluorouracil 11Capecitabine 9Surveys and Questionnaires 8Leucovorin 8Irinotecan 8Cisplatin 8Bevacizumab 8Standard of Care 5Gemcitabine 5Drug Therapy 4S 1 (combination) 3Radiotherapy 3Nivolumab 3Interviews as Topic 3IFL protocol 3Educational Status 3Cyclophosphamide 3Colonoscopy 3Blood Specimen Collection 35,10-methylenetetrahydrofolic acid 3trebananib 2tivozanib 2pembrolizumab 2Taxes 2Remote Patient Monitoring 2Pemetrexed 2Panitumumab 2Ocoxin 2N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Neoplasms × Observation × Clear all
NCT05620537 2023-02-13

A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients

Jinling Hospital, China

Completed
808 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡